Itaspor Powder contains Itraconazole 1% w/w, an antifungal agent belonging to the triazole class, indicated for the treatment of various superficial and systemic fungal infections. Itraconazole exerts its antifungal effect by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is essential for the conversion of lanosterol to ergosterol, a critical component of fungal cell membranes. This disruption results in increased membrane permeability and ultimately fungal cell death. Itaspor Powder is primarily used in the management of dermatophytosis, candidiasis, and other fungal infections affecting the skin, hair, and nails. The formulation allows for topical application, providing targeted antifungal activity with minimal systemic absorption, thereby reducing the risk of systemic side effects. It is suitable for patients requiring localized treatment of fungal infections, including tinea corporis, tinea cruris, and onychomycosis adjunct therapy. Patients should apply the powder to the affected area as directed by a healthcare professional, ensuring the area is clean and dry prior to application. Caution is advised in individuals with known hypersensitivity to itraconazole or other azole antifungals. Use during pregnancy and lactation should be under medical supervision. Adverse effects are generally mild and may include local irritation or itching.